Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy (Q35000998)

5 August 2017

1 reference

title

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy (English)

1 reference

5 August 2017

Matthew A Movsesian

1

1 reference

5 August 2017

Rami Alharethi

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Expert Opinion on Investigational Drugs

5 August 2017

published in

1 reference

5 August 2017

volume

11

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1529-1536

1 reference

Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Voltage-dependent potentiation of the activity of cardiac L-type calcium channel alpha 1 subunits due to phosphorylation by cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Carvedilol titration in patients with congestive heart failure receiving inotropic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Coupling of beta-adrenergic receptors to cardiac L-type Ca2+ channels: preferential coupling of the beta1 versus beta2 receptor subtype and evidence for PKA-independent activation of the channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Effects of β-Adrenergic Blocking Therapy on Left Ventricular Diastolic Relaxation Properties in Patients With Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.11.1529

10.1517/13543784.11.11.1529

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference